http://www.fpnotebook.com/
Benzodiazepine antagonistAka: Flumazenil, Romazicon
- Indication
- Benzodiazepine Sedation reversal
- Contraindications
- Mixed drug overdose
- Chronic Benzodiazepine use
- Dosing
- Benzodiazepine Sedation Reversal
- Initial: 0.2 mg IV over 15 seconds
- Titrate: 0.2 mg each minute to 1 mg total
- Overdose Reversal
- Initial: 0.2 mg IV over 30 seconds
- Titrate: 0.3-0.5 mg q30 seconds to 3 mg total
- Repeat dosing protocol
- Repeat Dose: 0.005 mg/kg q1-2 minutes
- Maximum cumulative dose: 1 mg
- May repeat regimen every 20 minutes
- Benzodiazepine Sedation Reversal
- Precautions
- May cause acute withdrawal if physically dependence
- Do not give routinely to comatose patients
- Only use if identity of drug is known
- Reverses Seizure protection of Benzodiazepines
- Increases risk of drugs that lower Seizure threshold
- Pharmacokinetics
- Onset: 1 to 2 minutes
- Peak: 6 to 10 minutes
Flumazenil (C0016293) | |
|---|---|
| Definition (MSH) | A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses. |
| Definition (NCI) | An imidazo-benzodiazepine derivative, effective in reversing benzodiazepine-induced activities. Flumazenil antagonizes the benzodiazepine binding site of the gamma-aminobutyric acid (GABA)/benzodiazepine receptor complex in the central nervous system (CNS), thereby preventing the chloride channel opening events and inhibiting neuronal hyperpolarization. As a result, flumazenil reverses benzodiazepine-induced effects including sedation, psychomotor deficits, amnesia, and hypoventilation in a dose-dependent manner. |
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D005442 |
| English | Flumazenil, FLUMAZENIL PREPARATION, Flumazepil |
| Spanish | flumacenil, flumazenil |
| Parent Concepts | Benzodiazepinones (C0005065), Neuroprotective Agents (C0242912), [AD900] ANTIDOTES/DETERRENTS, OTHER (C0973464), Benzodiazepine antagonist (C0360298) |
| Sources | AOD, CSP, MSH, MTHSPL, NCI, NDFRT, RXNORM, SCTSPA, SNOMEDCT, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
Romazicon (C0591091) | |
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D005442 |
| English | Anexate, Hoffman La Roche Brand of Flumazenil, Hoffman-La Roche Brand of Flumazenil, Lanexat, Roche Brand of Flumazenil, Romazicon |
| Sources | MSH, NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |